U.S. Food and Drug Administration (FDA) in February 2011 and has been available in countries recognizing the CE mark since 2008. Hologic’s 3D mammography technology is available in 46 states and 29 countries outside the U.S.
Hologic’s 3D mammography system placed first in the digital mammography category in the KLAS 2012 annual survey of healthcare executives and clinicians. 3D mammography was recently selected by AuntMinnie as the “hottest clinical procedure” of the year for the third year in a row. AuntMinnie is the largest and most comprehensive community Web site for medical imaging professionals worldwide. In October, the Cleveland Clinic picked 3D mammography as one of the Top 10 Medical Innovations for 2013 at the Clinic's 10th annual Medical Innovation Summit.
Fifteen of the clinical papers and over 50 of the workshops, seminars, poster sessions and scientific papers to be presented at the conference are on 3D mammography (breast tomosynthesis). Clinical presentations cover the use of tomosynthesis in screening and diagnostic applications.
Hologic is once again offering RSNA meeting attendees sixteen 75-minute sessions with hands-on experience reading 3D breast tomosynthesis images in combination with conventional and synthesized 2D images. Brief lectures will provide an overview of the technologies prior to the hands-on sessions. Each program will be taught by a leading breast imaging radiologist. Conference attendees can register to take a workshop through the RSNA meeting web site.
Some of Hologic’s other advances in breast tomosynthesis on display at the conference include its tomosynthesis biopsy option for use with the Affirm™ biopsy guidance system and its C-View™ synthesized 2D image option. The tomosynthesis biopsy option is CE marked and is pending FDA clearance. The C-View Synthesized 2D image option received CE marking in 2011 and received a favorable vote for approval from an FDA Advisory Panel in October 2012.
For more information: www.hologic.com
July 29, 2024 
